About

About Bened Biomedical Co., Ltd. Founded in 2015 in Taipei, Taiwan, Bened Biomedical Co., Ltd. is a global pioneer in microbiome science, specializing in the development of psychobiotics and microbiome-based therapeutics for neurological, immunological, metabolic, and allergic disorders. With a science-driven mission and a commitment to innovation, Bened is transforming how the world approaches mental wellness and disease prevention through microbiome modulation. Our flagship psychobiotic strain, PS128™, has been widely researched for its beneficial effects on mental health and neurodevelopmental conditions. The company has built an extensive clinical pipeline targeting stress, anxiety, autism spectrum disorder (ASD), Parkinson’s disease, cognitive decline, immune health, metabolic disorders, and more—providing safe, effective, and natural options for improving health through the gut-brain axis. Backed by strong R&D capabilities, Bened Biomedical holds 93 patents across 29 countries and has conducted 23 published human clinical studies to date. Our dedication to scientific integrity and product efficacy makes us a trusted partner in both consumer healthcare and the pharmaceutical space. The company name—“Bened,” from the Latin word meaning “full of blessings”—reflects our vision to deliver life-enhancing innovations to people worldwide. Our team of researchers and product developers work at the intersection of biotechnology, clinical science, and functional health, bringing microbiome-based solutions from the lab to everyday life. Key Achievements & Highlights: Scientific Leadership: 93 patents granted in 29 countries and 23 published human clinical trials across multiple health indications. Top Psychobiotic Brand: Our core product, Neuralli™ (PS128™), is recognized globally and ranked among the top 3 psychobiotic brands worldwide. Global Reach: Bened products are available in over a dozen countries through direct-to-consumer (DTC) platforms, clinical distribution, and international partnerships. Evidence-Based Formulations: All products are supported by peer-reviewed research and clinical studies ensuring safety, efficacy, and compliance with international standards. Bened Biomedical is uniquely positioned to lead the next wave of health innovation—where the microbiome meets neuroscience, and cutting-edge biotechnology powers personalized, natural health solutions. We welcome collaborations with partners who share our commitment to advancing science and improving quality of life through microbiome innovation. Partner with Bened to shape the future of health—where science meets the microbiome. Founded in 2015 in Taipei, Taiwan, Bened Biomedical Co., Ltd. is a global leader of microbiome-based products. The company uses its own patented strains to develop microbiome-based therapy for neuropsychological, aging-related, allergic, immunological, and metabolic disorders. Several milestones have been completed to demonstrate the efficacy and safety of Lactobacillus plantarum PS128®, through a series of successful clinical studies targeting either patients or healthy people. We continue to build up a pipeline of clinical studies including research on stress, anxiety, Autism, Parkinson’s disorder, etc. Based on past research and commercial performance, in 2020 Bened was named as one of the Top 10 key Players in Psychobiotic Supplements Market by Future Market Insights. Our mission is to develop best-of-breed psychobiotics to effectively prevent and treat neuropsychological disorders for the global community. The name “Bened,” derived from the Latin word for “full of blessings,” affirms the brand’s hope to bless the world through its products.